Chemoinformaics analysis of Myristyl palmitate
| Molecular Weight | 452.808 | nRot | 27 |
| Heavy Atom Molecular Weight | 392.328 | nRig | 48 |
| Exact Molecular Weight | 452.459 | nRing | 0 |
| Solubility: LogS | -4.527 | nHRing | 0 |
| Solubility: LogP | 4.032 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 92 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 32 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 60 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 30 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 91.7116 |
| nHD | 0 | BPOL | 62.7964 |
| QED | 0.18 |
| Synth | 7.152 |
| Natural Product Likeliness | 1.533 |
| NR-PPAR-gamma | 0.149 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.999 |
| Pgp-sub | 0.973 |
| HIA | 0.929 |
| CACO-2 | -5.368 |
| MDCK | 0.0000235 |
| BBB | 0.294 |
| PPB | 0.868045 |
| VDSS | 2.517 |
| FU | 0.139409 |
| CYP1A2-inh | 0.002 |
| CYP1A2-sub | 0.98 |
| CYP2c19-inh | 0.029 |
| CYP2c19-sub | 0.929 |
| CYP2c9-inh | 0.053 |
| CYP2c9-sub | 0.181 |
| CYP2d6-inh | 0.921 |
| CYP2d6-sub | 0.872 |
| CYP3a4-inh | 0.918 |
| CYP3a4-sub | 0.936 |
| CL | 2.321 |
| T12 | 0.001 |
| hERG | 0.929 |
| Ames | 0.045 |
| ROA | 0.998 |
| SkinSen | 0.004 |
| Carcinogencity | 0.666 |
| EI | 0.004 |
| Respiratory | 0.965 |
| NR-Aromatase | 0.331 |
| Antiviral | No |
| Prediction | 0.664079 |